Percheron Therapeutics LimitedASX: PER

First Patient Dosed in ATL1102 Phase IIb DMD Trial

Jun 8, 2023 at 2:58 AM UTC · Issued by Percheron Therapeutics Limited

Percheron Therapeutics Limited has released a press release.

View Attachment